Skip to main content
ABI logo

VictoryShares Pioneer Asset-Based Income ETF

Qualité des données : 0%
ABI
NASDAQ Financial Services Asset Management
24,78 €
▼ 0,13 € (-0,50%)
Company Details

Under normal circumstances, the fund invests at least 80% of its net assets in various U.S. dollar-denominated asset-based income investments. Asset-based income investments include, but are not limited to, securitized assets, such as ABS, including private and multi-class structures, pass-through certificates, residual certificates, and other instruments secured by financial, physical, and/or intangible assets.

Fourchette du Jour
Fourchette 52 Semaines
Volume
Ouverture —
Moyenne 50J / 200J
Moyenne 50J / 200J

Performance

Low (2,8%) → Stabilizing
1W
▼ -0,48%
1M
▼ -0,56%
3M
▼ -0,44%
6M
▼ -1,04%
YTD
▼ -0,16%

1W loss (-0.48%) is smaller than 1M (-0.56%) — decline may be easing

Quick Summary

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

Valorisation

P/E Ratio
N/A
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Comparaison Sectorielle

vs médiane du secteur Financial Services (2698 pairs)
Métrique Action Médiane du Secteur
P/E 11,1
P/B 1,2
ROE % 9,2
Net Margin % 9,4
Rev Growth 5Y % 5,8
D/E 0,5

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

Insider Trading Activity

Buy ratio (90d) 0.0%
5 transactions
Date Insider Type Shares Price Value
Mar 4, 2026
Abi-Saab Walid
Chief Medical Officer
grant 108 900
Mar 4, 2026
Abi-Saab Walid
Chief Medical Officer
sell 808 9,06 € 7 320,48 €
Mar 2, 2026
Abi-Saab Walid
Chief Medical Officer
sell 1 660 9,95 € 16 517,00 €
Aug 8, 2025
GILEAD SCIENCES, INC.
10% Owner
buy 4 591 840
Jun 27, 2025
Abi-Saab Walid
Chief Medical Officer
sell 1 466 13,92 € 20 406,72 €

ETFs Holding This Stock

RMBTX RMBTX
3,51% weight
INVYX INVYX
2,73% weight
PIEKX PIEKX
2,73% weight
PIIFX PIIFX
2,73% weight
BGPWX BGPWX
2,53% weight
BGPTX BGPTX
2,53% weight
BGPKX BGPKX
2,53% weight
BGPVX BGPVX
2,53% weight
BGPFX BGPFX
2,53% weight
BSGPX BSGPX
2,53% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) N/A
ROE N/A ROA N/A
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) N/A
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value N/A
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio N/A Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap N/A Enterprise Value N/A
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum N/A